Silencing of Mcl-1 overcomes resistance of melanoma cells against TRAIL-armed oncolytic adenovirus by enhancement of apoptosis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Journal of Molecular Medicine (99:9) - Berlin ; Heidelberg : Springer Nature - S. 1279-1291
- Ereignis
-
Veröffentlichung
- (wo)
-
Berlin
- (wer)
-
Technische Universität Berlin
- (wann)
-
2021
- Urheber
-
Tolksdorf, Beatrice
Zarif, Sina
Eberle, Jürgen
Hazini, Ahmet
Dieringer, Babette
Jönsson, Franziska
Kreppel, Florian
Kurreck, Jens
Fechner, Henry
- DOI
-
10.14279/depositonce-12755
- Handle
-
11303/13982
- URN
-
urn:nbn:de:101:1-2021121517151707045836
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:22 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Tolksdorf, Beatrice
- Zarif, Sina
- Eberle, Jürgen
- Hazini, Ahmet
- Dieringer, Babette
- Jönsson, Franziska
- Kreppel, Florian
- Kurreck, Jens
- Fechner, Henry
- Technische Universität Berlin
Entstanden
- 2021
Ähnliche Objekte (12)
Silencing of Mcl-1 overcomes resistance of melanoma cells against TRAIL-armed oncolytic adenovirus by enhancement of apoptosis
HSF1 overexpression enhances oncolytic effect of replicative adenovirus
Establishing Suspension Cell Cultures for Improved Manufacturing of Oncolytic Adenovirus
Hepatocellular carcinoma-targeting oncolytic adenovirus overcomes hypoxic tumor microenvironment and effectively disperses through both central and peripheral tumor regions
Effects of pre-existing anti-adenovirus antibodies on transgene expression levels and therapeutic efficacies of arming oncolytic adenovirus
Targeting the Retinoblastoma/E2F repressive complex by CDK4/6 inhibitors amplifies oncolytic potency of an oncolytic adenovirus
Ixovex-1, a novel oncolytic E1B-mutated adenovirus
Oncolytic adenovirus encoding apolipoprotein A1 suppresses metastasis of triple-negative breast cancer in mice
Combination of autophagy inducer rapamycin and oncolytic adenovirus improves antitumor effect in cancer cells
Nonclinical characterization of ICVB-1042 as a selective oncolytic adenovirus for solid tumor treatment
Delivery of oncolytic vaccinia virus by matched allogeneic stem cells overcomes critical innate and adaptive immune barriers
Delivery of oncolytic vaccinia virus by matched allogeneic stem cells overcomes critical innate and adaptive immune barriers
Silencing of Mcl-1 overcomes resistance of melanoma cells against TRAIL-armed oncolytic adenovirus by enhancement of apoptosis
HSF1 overexpression enhances oncolytic effect of replicative adenovirus
Establishing Suspension Cell Cultures for Improved Manufacturing of Oncolytic Adenovirus
Hepatocellular carcinoma-targeting oncolytic adenovirus overcomes hypoxic tumor microenvironment and effectively disperses through both central and peripheral tumor regions
Effects of pre-existing anti-adenovirus antibodies on transgene expression levels and therapeutic efficacies of arming oncolytic adenovirus
Targeting the Retinoblastoma/E2F repressive complex by CDK4/6 inhibitors amplifies oncolytic potency of an oncolytic adenovirus
Ixovex-1, a novel oncolytic E1B-mutated adenovirus
Oncolytic adenovirus encoding apolipoprotein A1 suppresses metastasis of triple-negative breast cancer in mice
Combination of autophagy inducer rapamycin and oncolytic adenovirus improves antitumor effect in cancer cells
Nonclinical characterization of ICVB-1042 as a selective oncolytic adenovirus for solid tumor treatment
Delivery of oncolytic vaccinia virus by matched allogeneic stem cells overcomes critical innate and adaptive immune barriers
Delivery of oncolytic vaccinia virus by matched allogeneic stem cells overcomes critical innate and adaptive immune barriers
Silencing of Mcl-1 overcomes resistance of melanoma cells against TRAIL-armed oncolytic adenovirus by enhancement of apoptosis
HSF1 overexpression enhances oncolytic effect of replicative adenovirus
Establishing Suspension Cell Cultures for Improved Manufacturing of Oncolytic Adenovirus
Hepatocellular carcinoma-targeting oncolytic adenovirus overcomes hypoxic tumor microenvironment and effectively disperses through both central and peripheral tumor regions
Effects of pre-existing anti-adenovirus antibodies on transgene expression levels and therapeutic efficacies of arming oncolytic adenovirus
Targeting the Retinoblastoma/E2F repressive complex by CDK4/6 inhibitors amplifies oncolytic potency of an oncolytic adenovirus
Ixovex-1, a novel oncolytic E1B-mutated adenovirus
Oncolytic adenovirus encoding apolipoprotein A1 suppresses metastasis of triple-negative breast cancer in mice
Combination of autophagy inducer rapamycin and oncolytic adenovirus improves antitumor effect in cancer cells
Nonclinical characterization of ICVB-1042 as a selective oncolytic adenovirus for solid tumor treatment
Delivery of oncolytic vaccinia virus by matched allogeneic stem cells overcomes critical innate and adaptive immune barriers